Delivery Order SPE2DB24D2018-SPE2DB25FWWB0
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,670.90 by the Defense Logistics Agency for ProQuad vials, with an ultimate completion date of September 23, 2025. The contract employs firm fixed-price pricing and was awarded on a competitive basis without set-aside restrictions. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency on June 18, 2025, for the supply of ProQuad vials. The award is a non-set-aside, firm fixed price delivery order with an ultimate completion date of July 11, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,543.30 for ProQuad vials under a Defense Logistics Agency contract. The award, issued on September 2, 2025, with completion targeted for September 23, 2025, employs firm fixed-price terms with no set-aside designation. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, making this delivery order a component of the federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,874.40 by the Defense Logistics Agency on August 11, 2025, for the supply of ProQuad vials with an ultimate completion date of September 2, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,480.80 by the Defense Logistics Agency for the supply of ProQuad vials. The contract was competitively awarded on September 18, 2025, with an ultimate completion date of October 9, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating open competition among qualified vendors. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,543.30 by the Defense Logistics Agency (DLA) for ProQuad vials on May 6, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's Conshohocken facility. ProQuad is a combination vaccine used for immunization against...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWB0Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency (DLA) for ProQuad vials, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement that runs through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contract vehicle. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for ProQuad vials supports the military medical supply chain's vaccine inventory requirements and reflects AmerisourceBergen's ongoing role as a key vendor for federal healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/6/25 |